who is a good candidate for tirzepatide Medical Weight Loss? Save this. 📍Semaglutide. Tirzepatide. GLP-1.

Layered on top of the slowed gastric emptying the medication already causes, that makes nausea, bloating and diarrhoea more likely than in someone with an intact gallbladder

Key Takeaways: Mounjaro (which has the active ingredient Tirzepatide) treats diabetes in adults and aids in weight loss but can cause side effects like stomach issues, fatigue, and reactions at the injection site

It depends - but most patients age 35+ will have significant enough loss of fat volume in their cheeks, that some cheek filler could benefit them

Some people experience elevated heart rate and blood pressure

Approved for type 2 diabetes under the brand name Ozempic in 2017 and for chronic weight management as Wegovy in 2021, Semaglutide is administered weekly, offering a more convenient option compared to daily injections

Semaglutide is a once-weekly injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity